TIGIT and myelodysplastic syndrome: Previous studies have also characterized the expression profiles of TIGIT and its family molecules on NK cells in other hematologic malignancies, such as myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) (29, 30).